Galera Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Galera Therapeutics

11/05/2021 16:24

* Galera Therapeutics Inc  GRTX.OQ  reported a quarterly
adjusted loss of 75 cents​​ per share for the quarter ended
in March. The mean expectation of four analysts for the quarter
was for a loss of 83 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Galera Therapeutics Inc's reported EPS for the quarter was a
loss of 75 cents​.
* The mean earnings estimate of analysts had fallen by
about 4.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Galera Therapeutics Inc shares had fallen by 26.6% this
quarter and lost 36.8% so far this year.
* The company reported a quarterly loss of $18.72 million.
* Wall Street's median 12-month price target for Galera
Therapeutics Inc is $19.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 03:24 p.m. GMT.
​All figures in US dollars